Imunon to hold R&D Day on Sept. 23 focused on ovarian cancer trial

August 26, 2026 8:30 AM

Imunon, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announced it will host an R&D Day for investors, analysts, and media ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found